Sinteza S.A (STZ) Fair Value & Analysis
Basic Materials · RO · Market cap 28.1M RON
Fair value as of: Jun 24, 2026
From 12 valuation models · updated 8 days ago
Share price −12.2% over the past month.
Price vs Fair Value (12 months)
12‑month range 0.4130 RON – 0.8750 RON · fair‑value band 0.4000 RON – 0.4500 RON · the 0.4480 RON price screens above the 0.4200 RON fair value. As of Jun 24, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Sinteza S.A (STZ) currently trades at 0.4480 RON, while our model-based Fair Value estimate is 0.4200 RON — implying the stock looks roughly 6.3% overvalued today. We read business quality at 50/100 (solid quality), in the Basic Materials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).
Trailing-twelve-month revenue stands at 470K RON. Revenue grew 79.0% year over year. It earns a return on equity of -14.3%. Net debt stands at 3.5M RON. Fundamentals as of Jun 24, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jun 24, 2026. TTM = trailing twelve months.
About the company
Sinteza S.A. engages in the production and sale of basic organic chemical products. The company offers benzoic acid and liquid benzoic acid; and provides manufacturing services, as well as operates industrial platform. Its products are used in intermediates in organic syntheses, corrosion inhibitors, alkyd resins, auxiliary in polymerization processes, plastics, food preservatives, animal feed additives, pharmaceutical and cosmetic products, and others. Sinteza S.A. was founded in 1905 and is based in Oradea, Romania.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Sinteza S.A reported revenue of 335K RON in FY2025 versus 42.6M RON in FY2021, a compound −70.2%/yr. Reported net income was −3.4M RON in FY2025.
Is STZ fairly valued? → Check now
Similar stocks
6 more Chemicals stocks, each showing price versus our Fair Value estimate (as of Jun 24, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Linde plc LIN | €443.00 | €109.98 | -75% |
| Shin-Etsu Chemical Co SHECY | $22.77 | $13.22 | -42% |
| BASF SE BAS | €49.17 | €23.76 | -52% |
| Ningxia Baofeng Energy Group 600989 | ¥22.46 | ¥37.07 | +65% |
| Dow Inc D1OW34 | R$43.92 | R$86.14 | +96% |
| Ganfeng Lithium Group 002460 | ¥72.05 | ¥21.69 | -70% |
Explore undervalued stocks
More undervalued Basic Materials stocks →
Frequently asked questions
Is Sinteza S.A (STZ) undervalued?
What is the fair value of STZ?
What is the quality score of STZ?
What is the revenue of Sinteza S.A (STZ)?
What is the net profit margin of STZ?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.